Toumaz Named 'Cool Vendor' by Gartner

ToumazToumaz, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions, has been named as a 'Cool Vendor' by leading analyst firm Gartner, Inc. The 'Cool Vendors in Healthcare Providers 2010' report profiles five vendors worldwide who, in Gartner's assessment, exemplify innovative and potentially transformative solutions for global healthcare providers.

The report includes a recommendation to healthcare providers to "prepare for an explosion of innovations that use the potential of low-power, low-cost sensors combined with wireless networks. Since these technologies will generate large volumes of actionable data, executives will need to consolidate data and use decision support tools to enable deeper analysis of clinical processes, resources and outcomes." The authors of the report include senior Gartner analysts Jonathan Edwards, Barry Runyon, Vi Shaffer, Thomas J. Handler, M.D., John-David Lovelock, and Wes Rishel.

Toumaz's Sensium™ is the industry's first complete system for the development of end-to-end wireless vital signs monitoring and Body Area Networks (BAN) solutions. The revolutionary Sensium system provides the ability to continuously monitor multiple vital signs in real-time and feedback high-quality information to health professionals. In November 2009, Toumaz began clinical trials of its ultra-low power, ultra-small size Sensium "digital plaster" wireless body monitor, in a study conducted by a specialist clinical research team at Imperial College London. The trial has been carried out at St Mary’s Hospital, part of Imperial College Healthcare NHS Trust, and as expected, demonstrated that high quality physiological data can be continuously and wirelessly acquired by devices enabled by the Sensium platform.

Commenting on Toumaz's inclusion in the 'Cool Vendor' report, Toumaz CEO Professor Chris Toumazou said: "We are delighted to have been selected as a 'Cool Vendor' by Gartner, and we are very pleased that the transformative potential of our Sensium platform has been acknowledged in this way." He continued: "Sensium is a truly disruptive technology that provides a unique solution to addressing the medical management challenges now faced by healthcare providers across the globe. The benefits of more frequent and better structured patient monitoring have been well understood by hospital management teams for some time however, until Sensium, the costs and inconvenience have been prohibitive. Now, Sensium is providing a technology platform to create commercially-viable, clinically robust solutions and deliver a genuine revolution in wireless body monitoring - both in and out of hospital settings. We believe our 'Cool Vendor' designation from Gartner is a pleasing recognition of our solution and approach as we progress towards widespread commercial deployment of Sensium-enabled devices."

Related news articles:

About Gartner's Cool Vendors Selection Process
Gartner's listing does not constitute an exhaustive list of vendors in any given technology area, but rather is designed to highlight interesting, new and innovative vendors, products and services. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness of a particular purpose.

Gartner defines a cool vendor as a company that offers technologies or solutions that are: Innovative, enable users to do things they couldn't do before; Impactful, have, or will have, business impact (not just technology for the sake of technology); Intriguing, have caught Gartner's interest or curiosity in approximately the past six months.

For the full Gartner report, please visit: http://www.gartner.com/DisplayDocument?id=1334413&ref=g_sitelink&ref=g_SiteLink

About Sensium™
Toumaz's Sensium™ technology platform enables the non-intrusive acquisition of real-time, continuous physiological data for a wide range of health and lifestyle management applications, including remote healthcare, wellness and wireless monitoring at the bedside.

Sensium provides an open platform to develop revolutionary wireless devices that can continuously monitor multiple vital signs in real-time, and feedback high-quality information to health professionals via PCs, PDAs and smart phones.

About Toumaz
Toumaz is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - Sensium™ - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx)™ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...